Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.

Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE.

Cancer Causes Control. 2010 Jun;21(6):821-8. doi: 10.1007/s10552-010-9508-7. Epub 2010 Jan 19.

PMID:
20084540
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.

Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD.

Cancer. 1993 Feb 15;71(4):1258-65. Review.

PMID:
8435803
[PubMed - indexed for MEDLINE]
3.

Indicators of increased breast cancer risk in humans.

Page DL, Dupont WD.

J Cell Biochem Suppl. 1992;16G:175-82. Review.

PMID:
1469898
[PubMed - indexed for MEDLINE]
4.

Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.

Shirley SE.

West Indian Med J. 1999 Dec;48(4):173-8. Review.

PMID:
10639833
[PubMed - indexed for MEDLINE]
5.

Use of risk factors in counseling patients.

Love SM.

Hematol Oncol Clin North Am. 1989 Dec;3(4):599-610. Review.

PMID:
2691491
[PubMed - indexed for MEDLINE]
6.

Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists.

Fitzgibbons PL, Henson DE, Hutter RV.

Arch Pathol Lab Med. 1998 Dec;122(12):1053-5. Review.

PMID:
9870852
[PubMed - indexed for MEDLINE]
7.

[Significance of proliferative breast lesions around breast cancers].

Moriya T, Manabe T, Sakurai T, Sakamoto K.

Gan To Kagaku Ryoho. 1995 Apr;22 Suppl 1:42-5. Review. Japanese.

PMID:
7747991
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk